"A lot of Americans haven't even heard about this," Yam says. American's don't see COVID-19 as much as a health risk as they did before, she says, and the policy changes didn't necessary sway beliefs ...

Inside a lab in the French city of Orleans, scientists are testing out the limits of molecules in our body called messenger ...

The mRNA platform offers the advantage of faster vaccine production, which could allow more time to decide on which flu strains to cover.

Moderna said on Wednesday it would now operate full end-to-end manufacturing for its mRNA medicines in the U.S., marking a major step in strengthening the company's domestic production network.